Quick reference for the subcodes: R13.10: unspecified, the common starting code R13.11: oral phase, bolus control R13.12: oropharyngeal phase, billed most often R13.13: pharyngeal phase, aspiration focus R13.14: pharyngoesophageal phase, the UES code R13.19: other, cervical and neurogenic ASHA's ICD-10 reference confirms the R13.1 series for dysphagia and flags when the I69 sequelae codes take over for post-stroke cases, which is where we're headed next
Age, digestive conditions, certain medications, and even long-term stress can interfere
Yesthe test maps 14 pathways including connective tissue integrity and vascular function, identifying genetic variants that may increase bruising tendency
NAD+ supplementation is not FDA-approved for any anti-aging indication.
Related reading: TB-500 and Cell Migration Research Packaging and Stability Packaging can influence how strip formulations respond to moisture, oxygen, light, and temperature